Lawrence D. Stern

All filings by Lawrence D. Stern on record concern Talecris Biotherapeutics Holdings Corp. Between 30 September 2009 and 1 June 2011, the trades on record add up to 7 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 3 June 2011, reports a transaction in Talecris Biotherapeutics Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.